Home / Resource Library / Efficacy of high-frequency low-dose rituximab and acalabrutinib in chronic lymphocytic leukemia

Efficacy of high-frequency low-dose rituximab and acalabrutinib in chronic lymphocytic leukemia

Study examined acalabrutinib with rituximab for treatment of CLL.